Patients with POD1 GH less than 1.55ng/mL were more likely to have lower median preoperative GH levels (6.8ng/mL vs. 17.2ng/mL, p=0.025), and smaller mean maximal tumor diameter (1.5cm vs. 2.1cm, p=0.012). Here, GH1 is linked to neoplasm.